Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Weekly Deals, The Week Ending October 20, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Invo Healthcare Autism Home Support Services N/A Biotechnology Acquirer Target Price Syndax Pharmaceuticals, Inc. License to portfolio of small molecule... Read More »
Stat of the Week: Q3:17 Dollar Volume -57%
The Health Care M&A Report, Third Quarter 2017 is going to press, and we wanted to share a few relevant statistics. Following robust spending in the second quarter, the third quarter’s total is 57% lower. Here’s the chart. Deal value in the third quarter totaled $42.7 billion, which was 57% lower than the previous quarter, and 13% lower than Q3:16’s $48.9 billion total. Deals on the Technology side of health care usually take the lion’s share of spending in each quarter, and that held true in the third quarter. Technology deals accounted for 59% ($25.3 billion) of the quarter’s spending. The Services sectors contributed 41% ($17.4 billion) of the period’s spending. In... Read More »
Top 10 Transactions in Q3:17
Ten of the largest deals announced in the third quarter broke the $1.0 billion mark, for a total of $29.9 billion (70% of the quarter’s total spending of $42.7 billion). The largest transaction, Gilead Sciences’ $11.9 billion acquisition of biotech firm Kite Pharma, made up 28% of the quarter’s combined total spending. KKR & Co. made three of these billion-dollar acquisitions, either directly or through portfolio companies, for a total of nearly $7.3 billion. All three targets were publicly traded companies in very discrete fields: internet healthcare source WebMD, air ambulance company American Medical Response, and the... Read More »Health Care M+A Weekly Deals, The Week Ending October 13, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price The Halifax Group Delphi Behavioral Health Group, LLC N/A Lee Equity and FFL Partners Summit Behavioral Healthcare LLC N/A Biotechnology ... Read More »
Stat of the Week: Q3:17 Deal Volume Down 10%
As third quarters go in the cycle of healthcare mergers and acquisitions, big news is not expected. First quarter results may be exciting if the previous year’s fourth quarter was so hectic that a number of deals were pushed into the next year. Second quarters are usually a pause for breath as more books begin to circulate, indicating sellers’ interest in closing a deal by the end of the year. Third quarters tend to stay quiet, or even go dormant. Holidays and vacations are blamed, but for many deal makers, it’s a time to study and gird for the fourth quarter, when regulatory and tax deadlines sometimes loom. Preliminary results for Q3:17 show it is following the typical pattern. With 334... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
